{"name":"Zymeworks BC Inc.","slug":"zymeworks-bc-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ZW191","genericName":"ZW191","slug":"zw191","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ZW191","genericName":"ZW191","slug":"zw191","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPTTIwWklxdkNQdHBWdkl4UWRVdWNKQkFKU1lFOElaZ2xKWFJ1ZmxKMTkydG9RVHFnR05tNTFIQ2R5ckp2emVVbUlnLVNMeXh4OFU1S0M0Q0FEVWFvTFhqeUljdmUxLXR2SjczelRaaFpCOVFKcHprS19lS1hfTVRfSTlELUdUNTZXYTg1OTFpZTNMNmRrclJqeTdWV2lrRHRPT1JCaQ?oc=5","date":"2026-03-02","type":"pipeline","source":"Stock Titan","summary":"Zymeworks (NASDAQ: ZYME) seals $250M Ziihera royalty financing - Stock Titan","headline":"Zymeworks (NASDAQ: ZYME) seals $250M Ziihera royalty financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxQTTRMZWZuQ25xWU1VbWl4UlRyNWZndUdwSFpQOEhoTUJ4QlhZZXBCcEFBYkw2RXM1UEV4WDVqM2JJZTNmeU5DekVINXZRZHVpS0NPdG9GeWtqVjNneS1Tc3U2Ym5mMDZHdGlDWHd6RnliWmZ4TVRoQmxqVDJBZGgxeW5oZGJnS1liZ2pKemRCU3JvN1JWeUJmNklGbFd6dHRJLUhqcUh5el9Kd3FGdlFlZnRSNnpGVXp6TW9VQzJPX0dSOGFuQm5jRTFrNUx0V2JnRUdCOGQ5eFNxRlhHeEppbXRTcWdCdWNBX0RjWUZsNTdTSTh6cEFoVDZDMzBzSFhm?oc=5","date":"2026-03-02","type":"earnings","source":"GlobeNewswire","summary":"Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewswire","headline":"Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPRnMyamlQM3NNX3p1X2Q4YVNvT0g4UENnTEpiMGp2MTZMV191dm1YR3VhWTZUWHVwY2VmbjFSQ3djQURQRE5HallQODd0NzNiY2VqcExza3NwenJETklEeTZFTHFhbENad1JNMkNXLUZEVk12T1g5bngyOHFtTThzZkcxZjBtUGR0V1hIQ3NlcmpXSEJ2Mjc4bllMMFk5Tk1qSUNKWHVIdG4?oc=5","date":"2025-12-11","type":"pipeline","source":"Business in Vancouver","summary":"Could Zymeworks' blockbuster drug success revive Vancouver biotech scene? - Business in Vancouver","headline":"Could Zymeworks' blockbuster drug success revive Vancouver biotech scene?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxONmxvUmVpc3RXRTNOdGlWRUNUdmRzclFjOURHQnJiY2JtYUliaEFsamVuWDNEMk5FaUhvVjQtTjNsam1WUnE2Q25yQ0RWUy1mYkFnM1N0b1B5d1hUOGZMRXF6T25RMDlRWU5yaWg1enAzYzREVjdHRTdINlhYdmlzWVhvZ1cxSEJnUXk4Zng2SzVqWW9qc1U4Tm5UY1dJSVBWbWNGdkZpVmhGZw?oc=5","date":"2025-11-24","type":"pipeline","source":"The Globe and Mail","summary":"Zymeworks wanted to be Canada’s first Big Pharma. Despite two blockbusters-in-the-making, that’s no longer the plan - The Globe and Mail","headline":"Zymeworks wanted to be Canada’s first Big Pharma. Despite two blockbusters-in-the-making, that’s no longer the plan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxOZWhDb1F4UWVFOXNBZFNES3NfQ3BBUkc4bmZSSmdONjRYQjNUMENaWk9jLVdLSVJSYVRXMnQxanRFd19EazJOMXlrSDlHU1NSdm8zbHhiUlhnMjByUHVaYnBZbFBmZ0h3em1DM2J1QWkwWE5VU25tZ1BJckxVdVBiekRvQVFZc05QanAtbFg5RV81RjJlaGppLWhFMWJIU21JQzNyU2xDU1FkckZWNDNYUA?oc=5","date":"2025-11-17","type":"pipeline","source":"seekingalpha.com","summary":"Jazz Pharmaceuticals' And Zymeworks' Ziihera Success: A Pleasant Surprise (NASDAQ:JAZZ) - seekingalpha.com","headline":"Jazz Pharmaceuticals' And Zymeworks' Ziihera Success: A Pleasant Surprise (NASDAQ:JAZZ)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNVGFSemdKWmgxMFk4UTktWHNQYjdieXNVUE5vOHVCOF9qcUF2ZlVDU2xZS2wtb2RLS083LXJnV3ctaGcyNlVnMlU0UDV6Tk8zb3BtaHd4TFBJazhwTGtWYTU1eWRHc0pYUWVvdXdNaXBQT1l6YmlCZjBQeGtYemxzVUJ0cDZUSER5?oc=5","date":"2025-01-16","type":"pipeline","source":"Business in Vancouver","summary":"Opinion: Four trends to watch in B.C.'s tech sector - Business in Vancouver","headline":"Opinion: Four trends to watch in B.C.'s tech sector","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPZjNucG9tdDJUVXNZamdJWHBoTGxacVhvcVQybG9VaW5ibVZkRi1CVkN3LTlERWx1MFEtOWRpQTlqMzAwNFREN29oRm5kVEpoc042dG5ya1NlS1BRSThTLWZGa2pCMC1LdmMtV3pXRmxrQVQ2TW8wMWo3cUdZOVF1b1pOVDl4NWlqVHNNX1RpV01UMWNLa2U3VFhTUXprOHpZem9JbHBhMTd5MDRBVU9UbWk4a29CVlhad2c?oc=5","date":"2024-11-21","type":"regulatory","source":"The Globe and Mail","summary":"Rare milestone for Canadian biotech as Zymeworks-developed drug gets FDA approval - The Globe and Mail","headline":"Rare milestone for Canadian biotech as Zymeworks-developed drug gets FDA approval","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxON1hneVB5Y19LY25HcFZsNTRITTNPbmY0YzdfMGdsZEZnUTV4SFRfUE0xNDN5amNBLUVqby04MEVaV0tLOHhXWUFHM1NZTldDQ3dSY3YzX2pWcFRFangxVTdQTDBldW5RT2lkaXBWd1ZhMWI3TmtEYTlRVGoybHl0U2VRTk5INElJZmppaE9HU0w0MkotYXhXbXpMZnZKdENzV25GYQ?oc=5","date":"2024-11-21","type":"regulatory","source":"Business in Vancouver","summary":"FDA approves cancer drug developed by B.C.'s Zymeworks - Business in Vancouver","headline":"FDA approves cancer drug developed by B.C.'s Zymeworks","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi1wJBVV95cUxOZ1llU1V3UTFYYm81ODRnTVp4TmUzd2MxRWtFd2syMEhJWXFHc21YbjNIdmt1VHlTcEtGQWpHTFdycVlScWw2MzAybEhRaUJOYUhWSlE3ZmMwTGt0MTVjUDZsQ3ExZVFTbkMtV0dWTmpwOFpiS1RSVzdPcDA1U09kUWtpcW8wcmhCN01JMTd2LXJJMzNvR0w1ZlU2cU5hZHFjOHA5WTlnWk1tRmJnSWkzdTE1UF9GRkcxenhlUlcwMGVIck10YjJBcy1EZXoweUowT0UyQUQyazV4WnNNVHFDbFdabUZpU3JxSHFrMksyeG8xeTNkaFV6NGt4b3dkZUd1b2NnYW9PZE5yRkR6ZXVMRVlka1UxZ0l0WjBJRzdCeEQ2dEpsQTVneUR3TzdndE5WVUZqdV93LURQdjI1SUNVMkY1SV9IRmFMOU1YU2tDaFJvRnpDWk5n?oc=5","date":"2023-01-19","type":"trial","source":"prnewswire.com","summary":"Jazz Pharmaceuticals and Zymeworks Announce 84% Overall Survival at 18 Months from Phase 2 Trial Evaluating Zanidatamab in HER2-Expressing Metastatic Gastroesophageal Adenocarcinoma - prnewswire.com","headline":"Jazz Pharmaceuticals and Zymeworks Announce 84% Overall Survival at 18 Months from Phase 2 Trial Evaluating Zanidatamab ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxON2FfRXlXRHNGWkdyblhBUzRLNjEtQndQZEs1azE3RHFabmktSGdLTG1lZzRtUGwzQUgxYjN2enVoMTJGcjBXN1ZHSGFXLVY2VkZVRGpGbTM0VTZmTzlwbER2RkJoSm5yTlNIRGdPWHV0Nk5aNDdsR2V1dUIwODFzT3NfMUhIbk05UUY4RmlqT3lMTGRmVzc2SFNESHpuVWJOczQybmdsbmxoaHZvSVFITVNNQktRRGFBa0dERWpoRjlWWXBTZFRhY1gtSjBwOXlYTzV5UU1yb1hoSVB4ajI0UnBPYzUtaVc4SDNGZnJYaWJyQU1zcS01VHN3?oc=5","date":"2022-12-21","type":"trial","source":"prnewswire.com","summary":"Jazz Pharmaceuticals and Zymeworks Announce Jazz has Confirmed Opt-in and Advances Partnership for Zanidatamab - prnewswire.com","headline":"Jazz Pharmaceuticals and Zymeworks Announce Jazz has Confirmed Opt-in and Advances Partnership for Zanidatamab","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAJBVV95cUxNQVFNaFh0MDNBV1o3a0xXUUI2VVBDQUk2SkRON2RuQUZkSG95d21mUWR6LWw4NnJYYlVCYUltRTk4djBPMFY4Yk5ISUlnU0F5YmZBV2pjSE5OR0RQc0NYR0ZWSmZXQ0NYWG1id05PV0lmeUtQR3otOG9aa3RKakpBUHN4Y0YtcG1JZnlTSlVPVEthcU5GT094NGlOQ3lEb1FsNlFua1BMVUVoTTZSMEtxQ213RDB1a1RDdGNKb3gtbjVqLXUxR3Q0dERpUXllcnF6WkJLaUZiY1dlQkRZakE5N1ZyWkc1Y282VGV0NGstUTJHQ1ZMcnp4VVZBQ0NzQUtSY2FUak1ZWXEwWGhtNTM0WExLbWNUNDJwN3h0ajh1YVZOalpENHo3Xy04SEw?oc=5","date":"2022-10-19","type":"trial","source":"prnewswire.com","summary":"Jazz Pharmaceuticals and Zymeworks Announce Exclusive License Agreement to Develop and Commercialize Zanidatamab, a HER2-Targeted Bispecific Antibody - prnewswire.com","headline":"Jazz Pharmaceuticals and Zymeworks Announce Exclusive License Agreement to Develop and Commercialize Zanidatamab, a HER2","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOXzdicXVXYkxFSDh0QmU1UzJ3NnNYUGZ5ZktfcjdsN1VlMGxvY3AybUV5Y1U5eURmOXdKV24tZXA0TzlZYnYyMmlDeFEyWTBya2ZoWWpvT2J1RmFfbkVUTTZ3RWFiZ2JCWXJVMFc0bjVlTEZGY29xVnlGNmxUbGlsVWtKUVB3UkhvNFFlbjl1QWdORVBiS1ZuVHE0ZXA?oc=5","date":"2022-01-06","type":"pipeline","source":"Business in Vancouver","summary":"Zymeworks founder Ali Tehrani to step down as CEO by February - Business in Vancouver","headline":"Zymeworks founder Ali Tehrani to step down as CEO by February","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}